[Prostate cancer: update].

Abstract:

:The study of mitotic transduction of the signal showed that overexpression of pAkt and reduction in pERK expression would be associated a biological relapse. For tumors T1-3 N0M0 at the high risk of local relapse after prostatectomy, an immediate radiotherapy compared with a differed radiotherapy (at the time of PSA relapse), showed a significant reduction in the rate of local relapse and an ameliorated progression free survival. The effectiveness of the docetaxel was confirmed in two phase III randomized clinical trials : TAX-327 with 3 arms compared docetaxel every 21 days, docetaxel every 7 days and mitoxantrone. All arms were prednisone-based. An increase in overall survival, PSA progression free survival, PSA response rate and a pain reduction were highlighted in the docetaxel arm every 21 days. Docetaxel obtained at the end of this study the marketing authorization in this indication and became the treatment of reference. The SWOG 99-16 study compared the docetaxel estramustine association with the same arm of reference, mitoxantrone and prednisone, with similar results. The addition of estramustine to the docetaxel seems to improve the PSA response rate and progression free survival, but with a greater embolic toxicity. The addition of an antiangiogenic agent, the thalidomide, to docetaxel, improves progression free survival and overall survival. PSA responses were observed with an inhibitor of the proteasome, the bortezomib, in monotherapy, contrary to the imatinib which in monotherapy didn't have any effectiveness. Studies in association with docetaxel are ongoing. Some biological responses were observed with a vaccine anti MUC-1 and must be confirmed on a greater series of patients. The docetaxel impact on localized disease is actually evaluated.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Oudard S,Medioni J,Scotté F,Banu E

subject

Has Abstract

pub_date

2005-10-01 00:00:00

pages

865-73

issue

10

eissn

0007-4551

issn

1769-6917

journal_volume

92

pub_type

杂志文章,评审
  • [Better screening for work-related cancers: The experience of Brest University Hospital Occupational Disease Center inpatient service].

    abstract:INTRODUCTION:An in-patient clinical service has been set up in March 2016 in the Occupational Diseases Center of Brest University Hospital, France, to seek for work-relatedness of diseases in patients hospitalized into the oncology and hematology departments. We present here data after two years of existence. METHODS:...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.01.013

    authors: Grignoux J,Loddé B,Dewitte JD,Larabi L,Durand-Moreau Q

    更新日期:2020-04-01 00:00:00

  • [Update on lymphomas].

    abstract::Important progress have been recently achieved in the management of Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL). Prognostic factors are now better defined in HD thanks to new biologic and radiologic information which complete old and relevant clinical factors. These parameters are expected to improve decis...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Eghbali H,Soubeyran P,Soubeyran I,Monnerau A,Cazorla S

    更新日期:2002-01-01 00:00:00

  • [Life style and occupational factors and prevention of second primary cancers after childhood and adolescent cancer: Current state of knowledge].

    abstract:CONTEXT:Survival of children, adolescents and young adults treated for cancer increased with improved treatments. But there is still an increased risk of second primary cancer (SPC) in the long term compared to the population of the same age, especially related to treatments. A reflection on the follow-up of this popul...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2015.03.017

    authors: Duval S,Carretier J,Boyle H,Philip T,Berger C,Marec-Bérard P,Fervers B

    更新日期:2015-07-01 00:00:00

  • [P53 genes and solid tumors].

    abstract::The p53 gene is known to play a central role in cancer. In fact, no human tumor type is devoid of p53 mutations, although differences can be seen in the relative frequencies and patterns of nucleotide substitutions. Our work illustrates these differences, since frequencies of mutations ranged from 15 to 80% and the pa...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Theillet C

    更新日期:1993-08-01 00:00:00

  • [Endometrial cancer and tamoxifen. Discussion apropos of a series of cases].

    abstract::Tamoxifen is widely used nowadays in the management of breast cancer, having established its efficacy in this indication, especially for postmenopausal patients with ER-positive breast tumours. However, tamoxifen has recently been recognized as carcinogenic for the human endometrium, probably with an effect of duratio...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,多中心研究,评审

    doi:

    authors: Sasco AJ,Ah-Song R,Gendre I,Zlatoff P,Bobin JY,Hallonet P,Leduc B

    更新日期:1997-01-01 00:00:00

  • [Study of codon 72 of p53 gene as a risk-factor in cervical cancer in Senegal].

    abstract::Beside human papilloma virus infection, several genetic factors have been involved in susceptibility to cervical cancer. The arginine allele at codon 72 in p53 tumor suppressor gene has been reported to be a risk-factor in different ethnic groups. Our aim was to study this polymorphism as a risk-factor in Senegal. We ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2014.1911

    authors: Ndiaye R,Dem A,Mbaye PM,Guèye PM,Diop G,Diop PA,Faye O

    更新日期:2014-09-01 00:00:00

  • [Small cell bronchial cancer: epidemiology].

    abstract::Small cell lung carcinoma is the most frequent cancer in man. In France, the geographic distribution is not homogenous and the frequency is time-dependent. The main risk factors are smoking and some professional exposures. ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Flamant R,Hill C,Benhamou S

    更新日期:1987-01-01 00:00:00

  • [Cyclooxygenase 2 inhibitors and cancer chemoprevention].

    abstract::Chemoprevention is the use of natural or synthetic compounds in order to reverse, suppress or prevent the carcinogenic process. Among the many pathways dysregulated during the carcinogenic process, cyclooxygenase-2 (Cox2) seems to be one of the most promising pathways to target in order to achieve chemopreventive and ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Masmoudi A,Chevalier TL,Sabatier L,Soria JC

    更新日期:2004-05-01 00:00:00

  • [Chemotherapy with high-dose cisplatin in brain metastasis of lung cancers].

    abstract::CDDP is one of the most active single drugs in non small cell lung carcinoma. High doses of 200 mg/m2 are well tolerated when fractionated doses are used over a period of 5 d. Twenty-four consecutive patients (male, age range 38-70 y) with brain metastasis of lung carcinoma were included in this study. The total dose ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Kleisbauer JP,Guerin JC,Arnaud A,Poirier R,Vesco D

    更新日期:1990-01-01 00:00:00

  • [Technical considerations for KRAS testing in colorectal cancer. The biologist's point of view].

    abstract::Targeted therapy against the EGF receptor was shown to be effective in a subgroup of patients with KRAS wild-type colorectal cancer. Therefore, cetuximab (Erbitux) or panitumumab (Vectibix) obtained the authorization by the EMEA restricted to patients with KRAS wild-type tumours. KRAS mutational testing has become par...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2009.0996

    authors: Blons H,Laurent-Puig P

    更新日期:2009-12-01 00:00:00

  • [Radiotherapy for sarcoma: hadrontherapy, for whom and what for?].

    abstract::The radiobiological properties of the hadrons (neutrons, protons, carbon ions) led to their therapeutic use in sarcomas, as a referent therapy or as an alternative to photon therapy. An extensive review of the literature has been conducted to assess the present indications and the perspectives for hadrontherapy. Compa...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1125

    authors: Pommier P,Sunyach MP,Hu Y,Amsalem E,Claude L,Moncort-Boulch D,Toutenu P,Balosso J

    更新日期:2010-06-01 00:00:00

  • [Urinary incontinence and sexual dysfunction after treatment of localized prostate cancer: Results from a population aged less than 65years old].

    abstract:INTRODUCTION:An increasing number of patients with prostate cancer (PC) are diagnosed and treated. The aim of this study was to investigate urinary incontinence (UI) and sexual dysfunction (SD) two years after treatment for localized prostate cancer (PC). METHODS:This study followed all cases of localized PC diagnosed...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.09.011

    authors: Bessaoud F,Orsini M,Iborra F,Rebillard X,Faix A,Soulier M,Daurès JP,Trétarre B

    更新日期:2016-10-01 00:00:00

  • A phase I-II, dose-escalating trial of ZD9331 in combination with irinotecan (CPT11) in previously pretreated metastatic colorectal cancer patients.

    abstract:BACKGROUND:To establish the recommended dose (RD) of the thymidylate-synthase inhibitor ZD9331 administered with irinotecan (CPT-11) in patients with pretreated metastatic colorectal cancer, and to assess toxicity profile, pharmacokinetics (PK), and anti-tumor activity in a phase I/II open, multicenter, intrapatient ch...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Louvet C,André T,Gamelin E,Garcia ML,Saavedra A,Lenaers G,de Gramont A,Méry-Mignard D,Kalla S

    更新日期:2004-12-01 00:00:00

  • [Not Available].

    abstract:SURGICAL DE-ESCALATION FOR INVASIVE BREAST CANCER TREATMENT:A surgical therapeutic de-escalation is going to continue but necessarily has to design in a progressive careful way and especially arranged with the other practitioners and therapeutic methods. These strategies concern as well the surgery of the breast as tha...

    journal_title:Bulletin du cancer

    pub_type: 社论

    doi:10.1016/S0007-4551(16)30151-5

    authors: Houvenaeghel G,Cohen M,Bannier M,Jauffret C,Buttarelli M,Lambaudie E

    更新日期:2016-06-01 00:00:00

  • [Endothelin receptors in benign human tumours of uterine muscle].

    abstract::The endothelins (ET1, ET2, ET3) are a family of peptides that exert vasoactive and mitogenic effects. ETs bind to at least two subtypes of receptors: the ETA subtype is ET1 selective whereas the ETB subtype binds ET1, ET2 and ET3. By RT-PCR, we detected ETA receptor mRNA and ETB receptor mRNA in leiomyoma and in homol...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Breuiller-Fouché M,Honoré JC,Robert B,Fournier T,Vacher-Lavenu MC,Chapron C,Dubuisson JB,Ferré F

    更新日期:1999-09-01 00:00:00

  • Assessment of diagnostic tests.

    abstract::An increasing number of clinicians is to day aware of the need to assess their diagnostic tools. Despite the fact that monetary value is only one of the components of the cost of a diagnostic test, economical problems are decisive stimuli for such an effort. Any diagnostic test involves a cost which is borne by the pa...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Alperovitch A

    更新日期:1980-01-01 00:00:00

  • [History and new development of screening and evaluation methods of anticancer drugs used in vivo and in vitro].

    abstract::Screening methods for the detection of anticancer activity are of crucial importance in order to find solid tumor-specific agents. A review of past screening methods is followed by a description of present methodologies targetted toward the discovery of such agents. Finally, we discuss primary and secondary in vivo ev...

    journal_title:Bulletin du cancer

    pub_type: 历史文章,杂志文章,评审

    doi:

    authors: Bissery MC,Chabot GG

    更新日期:1991-01-01 00:00:00

  • Early diagnosis of gastrointestinal cancer.

    abstract::The earlier a gastro-intestinal cancer is treated the better will be the prospects of cure for the patient. It is therefore important to study the early clinical stages of the pathway which leads to the diagnosis of gastro-intestinal cancer in order to make this pathway short and quick. This paper identifies the delay...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Mac Adam DB

    更新日期:1980-01-01 00:00:00

  • [Cancer and pregnancy: the point of view of the chemotherapy oncologist].

    abstract::Having to start chemotherapy during pregnancy remains a rare event. The decision to proceed this treatment relies on the drugs used, the time of exposure for the foetus and the gestational age at the time of exposure. As a matter of fact, the mutagenicity potential of the chosen medicine has to be known, and consequen...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Pautier P,Lhomme C,Morice P

    更新日期:2002-09-01 00:00:00

  • [Spontaneous transformation and long term culture of foetal mouse glial cells (author's transl)].

    abstract::Six cell lines originated from foetal mouse brain were maintained in vitro for more than two years. The morphology of most of these cultures suggests their glial character. This is corroborated, for some lines, by the presence of specific glial protein (Glial fibrillary acidic protein, or GFAP). Five out of these line...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Coulomb B,Levy S,Maunoury R,Markovits P

    更新日期:1979-01-01 00:00:00

  • Pain burden in desmoid tumor patients: a survey of the French Advocacy Group SOS Desmoid.

    abstract:INTRODUCTION:The French Patient Advocacy Group SOS Desmoid conducted a survey to measure the pain burden of desmoid tumor patients. MATERIAL AND METHODS:We used a structured questionnaire to measure the occurrence and consequences of pain. RESULTS:The pain occurrence was approximately 63%. In one-third of the cases, ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2015.02.001

    authors: Rigaux P,Lefebvre-Kuntz D,Penel N,“SOS Desmoïde”.

    更新日期:2015-03-01 00:00:00

  • [Secondary non-Hodgkin's lymphomas].

    abstract::Developing a secondary non Hodgkin's lymphoma (NHL) more than 12 months after treatment for first cancer, is uncommon. Secondary NHL occurs sometimes after chronic lymphatic leukemia or Hodgkin's disease. The 20 years cumulative incidence rate is 3-5% after Hodgkin's disease. Secondary NHL seems less frequent after an...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Cappelaere P

    更新日期:1998-03-01 00:00:00

  • [COVID-19 impact on the cancer care structuration: Example of the multidisciplinary team meeting dedicated to oncology in Occitanie].

    abstract::This work examines the impact of the SARS-CoV2 epidemic and the organizational recommendations that have been issued since March 16 on tumor boards (TB) activity. The tumor board activity was measured from tumor board sheets extracted from the oncologic electronic file between January 7, 2019 and April 24, 2020. The p...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.05.001

    authors: Grosclaude P,Azria D,Guimbaud R,Thibault S,Daubisse-Marliac L,Cartron G,Renaudie MJ,Dalbies PA,Delord JP,Bauvin E

    更新日期:2020-01-01 00:00:00

  • [The problems raised by the irradiation of pregnant women. Effects of ionizing radiations on the embryon and foetus (author's transl)].

    abstract::In man, the period of maximum risk for the embryo and foetus is between the second and tenth week after conception. The most frequent and most severe malformation is microcephaly which in extreme cases is accompanied by mental retardation. The results of studies in experimental animals and man agree that it is impossi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Tubiana M

    更新日期:1979-01-01 00:00:00

  • [Oncolor is ten years old: the age of discretion for the Lorraine network in oncology].

    abstract::Oncolor, network in oncology in Lorraine, was born ten years ago, from a group of professionals in the field of oncology who worked closed together with regional administrative authorities. Oncolor was created with respect of equilibrium between the different regional partners avoiding struggle for power. Oncolor was ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Bey P,Bouvier R,David M,Delena G,Garin H,Kessler Y,Klein I,Krakowski I,Lang MP,Leclercq JM,Level MC,Luron R,May I,Nabet M,Ruck S,Sommelet D,Theobald S,Unvois R,Walter S

    更新日期:2004-07-01 00:00:00

  • [Neoadjuvant chemotherapy FEC-HD in locally advanced breast cancer].

    abstract::The tolerance and the clinical and histological efficacy of a neoadjuvant chemotherapy FEC-HD including hematopoietic growth factors have been studied in 40 patients with stade II or III breast cancer between February 1991 and February 1997. Four courses were given, every 21 days, with 5-fluorouracil (750 mg/m2/day D1...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Darut-Jouve A,Coudert B,Jolimoy G,Belichard C,Arnoud L,Guerrin J

    更新日期:1999-02-01 00:00:00

  • [Gliomas and BRCA genes mutations: fortuitous association or imputability?].

    abstract::BRCA is a tumor suppressor gene implicated in the major mechanisms of cellular stability in every type of cell. Its mutations are described in numerous cancers, mainly breast and ovarian in women. It was also found an increase of lifetime risk of pancreas, colon, prostate cancer or lymphoma in men carriers. We report ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2014.1952

    authors: Girardstein-Boccara L,Mari V,Met-Domestici M,Burel-Vandenbos F,Berthet P,Paquis P,Frenay MP,Lebrun-Frenay C

    更新日期:2014-09-01 00:00:00

  • [The management of the metastatic disease by the surgeons].

    abstract::The high rate of recurrence after apparently complete surgery and/or complete clinical response to chemotherapy implies that most patients have undetected minimal residual disease. Novel techniques such as laparoscopic or laparotomic fluorescence may prove to be crucial in reassessing the definition of primary outcome...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2013.1730

    authors: Mery E,Golzio M,Thibault B,Ferron G,Querleu D,Delord JP,Couderc B

    更新日期:2013-04-01 00:00:00

  • [Surgical treatment of carcinomas of the cervix stage III (author's transl)].

    abstract::This study is devoted to the analysis of the surgical treatment of cancer of the uterine cervix, stage III. Three circumstances are evaluated: - Stage III with urinary disease the purpose of the surgical treatment is most often to save the renal function;--Recurrences after radiotherapy where surgery is the only poss...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Rochard F,Michel G,Castaigne D,Lacour J

    更新日期:1980-01-01 00:00:00

  • [Sentinel node biopsy in breast cancer].

    abstract::As compared to conventional axillary dissection, the sentinel node technique is accompanied by reduced morbidity and shorter hospital stay. Based on available data, the use of this technique does not seem to yield higher rates of axillary recurrence. A combination of both radioisotope detection and blue dye increases ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2009.0879

    authors: Hindié E,Groheux D,Espie M,Bourstyn E,Toubert ME,Sarandi F,de Roquancourt A,Giacchetti S,Cuvier C,Cahen-Doidy L,Teyton P,Misset JL,Maylin C,Moretti JL

    更新日期:2009-06-01 00:00:00